Genomics Market worth 19.99 Billion USD by 2020 Genomics Market worth 19.99 Billion USD by 2020 | Page 18

TABLE OF CONTENTS 13 COMPANY PROFILES...............................................................................................................152 • (Overview, Financials, Products & Services, Strategy, & Developments)* • 13.1 INTRODUCTION.............................................................................................................................................................152 • 13.2 THERMO FISHER SCIENTIFIC, INC................................................................................................................................153 • 13.3 AGILENT TECHNOLOGIES, INC......................................................................................................................................156 • 13.4 AFFYMETRIX, INC..........................................................................................................................................................159 • 13.5 BEIJING GENOMICS INSTITUTE (BGI)...........................................................................................................................161 • 13.6 BIO-RAD LABORATORIES, INC.......................................................................................................................................163 • 13.7 CEPHEID, INC................................................................................................................................................................165 • 13.8 EUROFINS GENOMICS, INC. (SUBSIDIARY OF EUROFINS SCIENTIFIC GROUP).........................................................167 • 13.9 GE HEALTHCARE............................................................................................................................................................169 • 13.10 ILLUMINA, INC...............................................................................................................................................................172 • 13.11 QIAGEN N.V....................................................................................................................................................................175 • 13.12 ROCHE HOLDING AG.....................................................................................................................................................177 • *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies. 14 APPENDIX................................................................................................................................179 • 14.1 DISCUSSION GUIDE......................................................................................................................................................179 • 14.2 COMPANY DEVELOPMENTS (2012-2015)....................................................................................................................183 • 14.2.1 THERMO FISHER SCIENTIFIC, INC..............................................................................................................183 • 14.2.2 AGILENT TECHNOLOGIES, INC...................................................................................................................184 • 14.2.3 AFFYMETRIX, INC........................................................................................................................................185 • 14.2.4 BEIJING GENOMICS INSTITUTE (BGI).........................................................................................................186 • 14.2.5 BIO-RAD LABORATORIES, INC....................................................................................................................188 • 14.2.6 EUROFINS GENOMICS, INC........................................................................................................................189 • 14.2.7 ILLUMINA, INC............................................................................................................................................189 • 14.2.8 QIAGEN N.V..................................................................................................................................................192 • 14.2.9 ROCHE HOLDING AG...................................................................................................................................193 • 14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE..............................................................................................194 • 14.4 AVAILABLE CUSTOMIZATIONS......................................................................................................................................194 • 14.5 RELATED REPORTS........................................................................................................................................................195 • [email protected] www.marketsandmarkets.com 18